GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23...
description
Transcript of GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23...
![Page 1: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/1.jpg)
GPC-IR to Characterize Macromolecular
Excipients in Pharmaceutical Formulations
Ming Zhou, David Dunn, William Carson,
Sidney Bourne & Tom Kearney
Spectra Analysis, Inc.
April 23, 2010
Contact: [email protected]
Tel. 508-281-62761
AAPS NERDG 2010 Annual Meeting Short Topic Presentation #5
![Page 2: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/2.jpg)
OUTLINE
GPC-IR Hyphenated Technology: Instrumentation
Excipient Characterization: Copovidone PVP/VAc
Excipient Degradation from HME Process: HPMCAS
Summary: GPC-IR Applications in Pharma Formulations
Q & A
2
![Page 3: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/3.jpg)
LC-IR Hyphenation
![Page 4: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/4.jpg)
Direct Deposition FTIR
![Page 5: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/5.jpg)
Direct Deposition FTIR & Data Processing
ZnSe Disk
![Page 6: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/6.jpg)
GPC-IR Technology: 3D View to Map out Polymer Compositions
6
![Page 7: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/7.jpg)
IR Spectrum of Copovidone Excipient - VP/VAc Copolymer
Peak 1680 cm-1 from VP comonomer
Peak 1740 cm-1 from VAc comonomer
![Page 8: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/8.jpg)
GPC-IR Chromatogram Overlay with Comonomer Ratios
Excipient Compositional Drift w/ MWD Vs. Bulk Average
Abs. Peak Ratio: AVA / AVP = (k1*b*MVA) / (k2*b*MVP) = k (MVA / MVP) ~ Comonomer Ratio
(Molecular Weight Distribution)
Bulk Average
Copovidone
![Page 9: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/9.jpg)
0
.1
.2
.3
.4
.5
.6
106 104 103 102105
max
. IR
abs
orba
nce
Molecular Weight
Copovidone: sample A
30
35
40
45
50molecular weightdistribution
% acetate com
onomer
comonomer compositiondistribution
Excipient Compositional Drift w/ MWD Vs. Bulk Average
Bulk Average40% VAc
![Page 10: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/10.jpg)
0
.1
.2
.3
.4
.5
.6
106 104 103 102105 Molecular Weight
Copovidone: sample Asample Bsample C
Copovidone MW Distributions from Different Suppliers (Manf. Processes)
max
. IR
abso
rban
ce
Copovidone A gave clear tablets while Copovidone C led to cloudy ones.
![Page 11: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/11.jpg)
0
.1
.2
.3
.4
.5
.6
106 104 103 102105Molecular Weight
Copovidone: sample A
30
35
40
45
50
% acetate com
onomer
Comonomer CompositionDistribution
sample Bsample C
0
.1
.2
.3
.4
.5
.6
106 104 103 102105
sample Bsample C
Bulk 40% VAc
max
. IR
abso
rban
ce Molecular WeightDistribution
Copovidone Compositional Driftsfrom Different Manf. Processes
Copovidone A gave clear tablets while Copovidone C led to cloudy ones.
![Page 12: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/12.jpg)
Excipient Characterization by GPC-IR
12
Copolymer Compositional Analysis with MW Distributions
• Comonomer Ratio Drift (Functional Groups) vs. Bulk Average
• Excipient Lot-to-Lot Variations: QbD Studies
Excipient Performance & Functional Group Correlations
• Hydrophobic/Hydrophilic Ratio Drift vs. Phase Separations
• Effects on Excipient Dissolution Behavior
Reference(1) Chemical Heterogeneity on Dissolution of HPMC,
EU J. of Pharma Sci., P392 (2009), A. Viriden et al.(2) Comp Drift Effect on Dissolution of PMMA/MAA,
Materials Letters, P1144 (2009), E. Manias et al.
![Page 13: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/13.jpg)
13
Excipient Degradation from Hot Melt Extrusion Process
Hot Melt Extrusion Process: To Make Solid Dispersions for Low Solubility Drugs to Improve Bioavailability
Degradation Issues• Excipient & API Degradation at High Temp. (100-200C)• Discoloration / Residues• Degradant / API Interactions
Process Variables• Temperature• Time• Torque
![Page 14: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/14.jpg)
GPC-IR to Analyze HPMCAS Degradation in HME Process
Samples: A- Not Processed; B- Processed at Low Temp.;C- Processed at High Temp. (Degradant peak around 14.5 min.)
![Page 15: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/15.jpg)
Degradant Identification from HPMCAS in HME Process (C)
IR Database Search Result: Succinic Acid
![Page 16: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/16.jpg)
Polymer Compositional Change from HPMCAS Degradation in HME
Functional Group Ratio Changes from High Temp Process (Sample C)
OH
-C=O
![Page 17: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/17.jpg)
GPC-IR Analysis of HPMCAS Degradation in HME Process
Fig. A Schematic Structure of HPMC-AS
Detected Degradant: Succinic AcidDetected Functionality Ratio Change: Hydroxyl Vs. CarbonylHelp Understand Excipient Degradation MechanismStudy Excipient / API InteractionsDefine Safe Process Window: QbD
CH3-C=O
HOOC-CH2-CH2-C=O
![Page 18: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/18.jpg)
HPMCAS Grade-to-GradeDifference (LF/MF/HF) by GPC-IR
MOCH3C
OH
HPCH3
AAcetyl
ASC=O
HOOC-CH2-CH2-C=O
CH3-C=O
-C-O-C-
![Page 19: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/19.jpg)
HPMCAS Grade-to-GradeDifference (LF/MF/HF) by GPC-IR
HPCH3
AcetylC=O
-C-O-C-
![Page 20: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/20.jpg)
Common Polymeric Excipients
20
Neutral Cellulose Derivatives• HydroxyPropyl Methoxy Cellulose (Hypromellose): HPMC• HydroxyPropyl Cellulose: HPC• Cellulose Acetate Butyrate: CAB
Acidic Cellulose Derivatives• HPMC Acetate Succinate: HPMC-AS• HPMC Phthalate: HPMC-P• Cellulose Acetate Phthalate: C-A-P
Copovidone: PolyVinyl Pyrrolidone / Vinyl Acetate – PVP/VAc
SoluPlus Terpolymer: PEG / PVAc / PVCap
Methacrylic or Methacrylate Copolymers: Eudragit
Polyethylene Oxide: PEO (MW > 20K) or PEG (MW < 20K), PEG/PPG
Excipient Combinations with Plasticizers and Additives
![Page 21: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/21.jpg)
Excipient Analysis with GPC-IRin Drug Formulations
• Polymeric Excipient Characterization
• Degradation in Process (Hot Melt Extrusion)
• Excipient / API Interactions
• Forced Degradation in Shelf Life Study
December 1, 2008: Vol. 5, No. 6The cover cartoon illustrates a solid dispersion assembly that is composed of entangled polymer chains with drug molecules embedded in the form of single molecule, small clusters, and/or large aggregates (amorphous).
![Page 22: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/22.jpg)
GPC-IR Applications for Excipient Analysis in Drug Formulations
ExcipientManufacturing
• Process Control• Lot-to-lot
Variations• CoA
• Novel Excipient R&D
• Trouble Shooting
Formulation Develop. Drug Manufacturing
• Incoming QC• Excipient Functionality• Formulation
Development• QbD
• Process Degradation (Hot Melt Extrusion)
• Define Safe Process Window / QbD
• Process Monitoring
• Trouble Shooting
Formulated DrugsShelf Life Stability
• Stressed Degradation
• De-Formulate Excipient Blends
• Trouble-Shoot Problem Drugs in the Market
Users: Excipient Pharma Co. Pharma Co.Manufacturers HME Service Providers Generic Drug Co.
![Page 23: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/23.jpg)
Excipient Degradation Analysisin HME Process by GPC-IR
23
Detect Degradation Intermediates with MW Distributions
Detect Functionality Changes
Probe Polymer Degradation Mechanism
Solve Degradation Problems
Understand Excipient / API Interactions
Define Safe Process Window: QbD
HME Process Monitoring: PAT
Various Macromolecular Excipients
Excipient Blends with Plasticizers and Additives
![Page 24: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/24.jpg)
Excipient QbD SpaceGPC-IR-Performance
Slide from USP International Excipient Workshop (July 2009)
GPC
IR
Performance
![Page 25: GPC-IR To Characterize Macromolecular Excipients In Pharmaceutical Formulations-AAPS-NERDG- 4 23 2010](https://reader034.fdocuments.us/reader034/viewer/2022051514/54987dd6ac7959222e8b567c/html5/thumbnails/25.jpg)
GPC-IR & HPLC-IR Applications
Excipient Characterization, Functionality & Degradation Analysis
Copolymer Compositional Analysis across MW Distribution
Polyolefin Copolymer Branching Analysis by High Temp GPC-IR
Polymer Blend Ratio Analysis across MW Distribution
Polymer Additive & Impurity Analysis
De-Formulation for Polymers and Additives: Competitive Analysis
Process Control & Optimization
Excipients, Plastics, Rubbers, Films, Fibers, Foams & Composites
Reactive Polymer Analysis for Coating, Adhesive, Sealant & Elastomer
Isomer Analysis for Chemicals, Forensics & Pharmaceuticals
General Analytical Capability: Trouble Shooting25